INPI’s performance during the COVID-19 pandemic
The suspension of deadlines was extended until the end of May
The Brazilian Patent and Trademark Office (INPI) has been taking a series of measures related to the COVID-19 pandemic. In addition to publishing a study about a series of drugs under research for the treatment of COVID-19, Ordinance No. 149/2020 was published on April 7, which amended Resolution INPI PR No. 239/19 and allowed the prior examination of patents related to innovations that can be used to hinder the pandemic from spreading.
Also, some cases were highlighted as a success for their direct application in the combat and treatment of COVID-19: (i) an aerator filter to transform the air infected with viruses and bacteria into clean air; (ii) a type of mechanical ventilation used to assist spontaneous breathing for COVID-19 called Ventilador de Exceção – Vexco; and (iii) a production of gel alcohol made from microfibrillated cellulose to replace carbomer.
Due to consequent restrictions caused to users, the INPI decided to extend the suspension of deadlines until May 31. Such suspension was established on March 16 and might be postponed again.
However, despite the above-mentioned suspension, the INPI is functioning normally.
For more information, visit Mattos Filho’s Intellectual Property practice.